<p>Apoptotic D384 cells were detected and monitored by Annexin V-FITC/PI staining. (A) A representative histogram is shown for each DhL concentration. Quadrant 1, PI (+) (cells undergoing necrosis); Quadrant 2, Annexin V-FITC (+) and PI (+) (cells in the late apoptosis and secondary necrosis); Quadrant 3, Annexin V-FITC (−) and PI (−) (living cells); Quadrant 4, Annexin V-FITC (+) and PI (−) (cells in the early apoptosis). (B) Apoptotic changes. The fractions of live (black bars), early apoptotic (gray bars), late apoptotic/secondary necrotic (white bars) and necrotic (striped bars) cells are shown. Symbols denote statistically significant differences: * p<0.01, ** p<0.001 and *** p<0.0001 with respect to control conditions for live cells, ...
<p>A. Flow cytometric analysis of apoptosis in human PDL cells stained with annexin V and PI. Dot pl...
<p>(A) U937 cells were treated with 1.4 µg/ml HF for 72 h. Detection of apoptotic cells after annexi...
<p>Untreated cells (A); cilengitide treated cells (B); RGDechi-hCit treated cells (C). Upper left qu...
<p>Unsynchronized (A) and synchronized (B) HeLa cells were treated with 0, 20, or 30 µM DhL for 24 o...
<p>(A). The chemical structure of DhL (B). Analysis of D384 cell viability upon DhL exposure using a...
<p>. The fluorescence profile of untreated HeLa cells. Untreated HeLa cells were collected and incub...
<p>(A) Synchronized HeLa cells were treated with 0–20 µM DhL for 72 h and subjected to DNA flow cyto...
<p>(A) DHA-induced concentration-dependent reduction of cell viability in A549 and PC-9 cells. Cells...
<p>D384 cells were exposed to 12.5, 15 and 17.5 μM DhL for 16 h. Total protein lysates were separate...
<p>Cell cycle analysis. D384 cells were exposed to 0 (C-, control), 5, 7.5 and 10 μM of DhL for 6, 1...
<p>A) TUNEL staining for apoptosis in HeLa cells after treatment for 48 h in control, FP and HF grou...
(A) Cell death was evaluated at 24, 48, 72, and 96 h cells dosed with 7 mM DHA. Cells categorized in...
<p>DH281, DH285 and DH287 induce apoptosis at different concentrations. HeLa or MRC5 cells were incu...
(A) Induction of cell apoptosis by FD268 at the increasing concentrations for 48h. Apoptotic cells w...
<p>HL-1 cells were pretreated as indicated. Then, (A) cells were treated with annexin-V/PI double st...
<p>A. Flow cytometric analysis of apoptosis in human PDL cells stained with annexin V and PI. Dot pl...
<p>(A) U937 cells were treated with 1.4 µg/ml HF for 72 h. Detection of apoptotic cells after annexi...
<p>Untreated cells (A); cilengitide treated cells (B); RGDechi-hCit treated cells (C). Upper left qu...
<p>Unsynchronized (A) and synchronized (B) HeLa cells were treated with 0, 20, or 30 µM DhL for 24 o...
<p>(A). The chemical structure of DhL (B). Analysis of D384 cell viability upon DhL exposure using a...
<p>. The fluorescence profile of untreated HeLa cells. Untreated HeLa cells were collected and incub...
<p>(A) Synchronized HeLa cells were treated with 0–20 µM DhL for 72 h and subjected to DNA flow cyto...
<p>(A) DHA-induced concentration-dependent reduction of cell viability in A549 and PC-9 cells. Cells...
<p>D384 cells were exposed to 12.5, 15 and 17.5 μM DhL for 16 h. Total protein lysates were separate...
<p>Cell cycle analysis. D384 cells were exposed to 0 (C-, control), 5, 7.5 and 10 μM of DhL for 6, 1...
<p>A) TUNEL staining for apoptosis in HeLa cells after treatment for 48 h in control, FP and HF grou...
(A) Cell death was evaluated at 24, 48, 72, and 96 h cells dosed with 7 mM DHA. Cells categorized in...
<p>DH281, DH285 and DH287 induce apoptosis at different concentrations. HeLa or MRC5 cells were incu...
(A) Induction of cell apoptosis by FD268 at the increasing concentrations for 48h. Apoptotic cells w...
<p>HL-1 cells were pretreated as indicated. Then, (A) cells were treated with annexin-V/PI double st...
<p>A. Flow cytometric analysis of apoptosis in human PDL cells stained with annexin V and PI. Dot pl...
<p>(A) U937 cells were treated with 1.4 µg/ml HF for 72 h. Detection of apoptotic cells after annexi...
<p>Untreated cells (A); cilengitide treated cells (B); RGDechi-hCit treated cells (C). Upper left qu...